7JIJ image
Entry Detail
PDB ID:
7JIJ
Title:
ATP-bound AMP-activated protein kinase
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2020-07-23
Release Date:
2021-07-28
Method Details:
Experimental Method:
Resolution:
5.50 Å
R-Value Free:
0.32
R-Value Work:
0.24
R-Value Observed:
0.25
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:5'-AMP-activated protein kinase catalytic subunit alpha-1
Chain IDs:B (auth: A)
Chain Length:484
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:5'-AMP-activated protein kinase subunit beta-2
Chain IDs:C (auth: B)
Chain Length:198
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:5'-AMP-activated protein kinase subunit gamma-1
Chain IDs:D (auth: G)
Chain Length:306
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Maltose/maltodextrin ABC transporter substrate-binding protein MalE
Chain IDs:A (auth: M)
Chain Length:373
Number of Molecules:1
Biological Source:Escherichia coli
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
TPO B THR modified residue
Peptide-like Molecules
PRD_900001
Primary Citation

Abstact

Adenosine monophosphate (AMP)-activated protein kinase (AMPK) regulates metabolism in response to the cellular energy states. Under energy stress, AMP stabilizes the active AMPK conformation, in which the kinase activation loop (AL) is protected from protein phosphatases, thus keeping the AL in its active, phosphorylated state. At low AMP:ATP (adenosine triphosphate) ratios, ATP inhibits AMPK by increasing AL dynamics and accessibility. We developed conformation-specific antibodies to trap ATP-bound AMPK in a fully inactive, dynamic state and determined its structure at 3.5-angstrom resolution using cryo-electron microscopy. A 180° rotation and 100-angstrom displacement of the kinase domain fully exposes the AL. On the basis of the structure and supporting biophysical data, we propose a multistep mechanism explaining how adenine nucleotides and pharmacological agonists modulate AMPK activity by altering AL phosphorylation and accessibility.

Legend

Protein

Chemical

Disease

Primary Citation of related structures